USS Investment Management Ltd Has $83.74 Million Stock Holdings in Teleflex Incorporated (NYSE:TFX)

USS Investment Management Ltd cut its holdings in Teleflex Incorporated (NYSE:TFX) by 9.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 222,570 shares of the medical technology company’s stock after selling 23,708 shares during the quarter. USS Investment Management Ltd owned about 0.48% of Teleflex worth $83,740,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of TFX. BlackRock Inc. lifted its stake in shares of Teleflex by 6.9% in the second quarter. BlackRock Inc. now owns 4,044,235 shares of the medical technology company’s stock worth $1,339,247,000 after buying an additional 259,880 shares during the last quarter. State Street Corp lifted its stake in shares of Teleflex by 1.4% in the fourth quarter. State Street Corp now owns 1,907,226 shares of the medical technology company’s stock worth $717,956,000 after buying an additional 27,173 shares during the last quarter. Parnassus Investments CA lifted its stake in shares of Teleflex by 3.0% in the third quarter. Parnassus Investments CA now owns 486,333 shares of the medical technology company’s stock worth $165,232,000 after buying an additional 14,078 shares during the last quarter. Bessemer Group Inc. lifted its stake in shares of Teleflex by 0.7% in the fourth quarter. Bessemer Group Inc. now owns 358,401 shares of the medical technology company’s stock worth $134,917,000 after buying an additional 2,337 shares during the last quarter. Finally, Carillon Tower Advisers Inc. lifted its stake in shares of Teleflex by 360.1% in the third quarter. Carillon Tower Advisers Inc. now owns 221,792 shares of the medical technology company’s stock worth $75,353,000 after buying an additional 173,592 shares during the last quarter. Hedge funds and other institutional investors own 90.73% of the company’s stock.

A number of analysts have recently weighed in on the stock. Barclays set a $365.00 price objective on shares of Teleflex and gave the stock a “hold” rating in a research note on Friday, November 1st. Needham & Company LLC boosted their price objective on shares of Teleflex from $408.00 to $423.00 and gave the stock a “buy” rating in a research note on Friday, January 31st. UBS Group boosted their price objective on shares of Teleflex from $415.00 to $430.00 and gave the stock a “buy” rating in a research note on Wednesday, December 18th. Wells Fargo & Co boosted their price objective on shares of Teleflex from $415.00 to $425.00 and gave the stock an “overweight” rating in a research note on Friday, January 17th. Finally, Morgan Stanley boosted their price objective on shares of Teleflex from $392.00 to $405.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 17th. Three analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $400.60.

In related news, CFO Thomas E. Powell sold 5,000 shares of the company’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $348.70, for a total transaction of $1,743,500.00. Following the completion of the transaction, the chief financial officer now directly owns 15,697 shares in the company, valued at approximately $5,473,543.90. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Stephen K. M.D. Klasko sold 200 shares of the company’s stock in a transaction on Monday, January 27th. The shares were sold at an average price of $375.71, for a total transaction of $75,142.00. Following the transaction, the director now owns 936 shares of the company’s stock, valued at $351,664.56. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,700 shares of company stock valued at $2,342,968. Corporate insiders own 2.36% of the company’s stock.

NYSE:TFX traded up $5.02 during trading hours on Friday, hitting $386.80. 6,767 shares of the company traded hands, compared to its average volume of 174,076. The stock has a market capitalization of $17.44 billion, a price-to-earnings ratio of 41.05, a P/E/G ratio of 2.07 and a beta of 0.94. Teleflex Incorporated has a twelve month low of $269.88 and a twelve month high of $390.21. The firm has a 50-day moving average of $378.43 and a 200 day moving average of $355.70. The company has a current ratio of 2.33, a quick ratio of 1.44 and a debt-to-equity ratio of 0.72.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

See Also: Technical Indicators – What is a Golden Cross?

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.